Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Irish

Endo-Agreement

More Like This

PR Newswire associated0

Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics

PR Newswire associated0

Endo Announces Divestiture of International Pharmaceuticals Business

Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting

PR Newswire associated0

Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa

Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

PR Newswire associated0

Endo's Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada

Incyte to Unveil New Data from its Dermatology Portfolio at 2025 American Academy of Dermatology (AAD) Annual Meeting

Innovaderm Research Rebrands as Indero, a Dual-Focus CRO